Back

Boosting small heat shock proteins lowers cardiomyocyte passive stiffness in experimental heart failure with preserved ejection fraction

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Basic Science Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Mark Waddingham

National Cerebral & Cardiovascular Center, Suita (Japan)

9 More presentations in this session

Presentation thumbnail
Enhanced activation of RSK1 in the nucleus reduces compensated hypertrophy induced by alpha1-adrenergic receptor agonist phenylephrine in mice in vivo
Professor A. Clerk (Reading, GB)
Abstract
Presentation thumbnail
MiR-126 is involved in allograft vasculopathy
Mr W. Heggermont (Aalst, BE)
Abstract
Presentation thumbnail
Associations between myocardial fibrosis-linked microRNAs and serum markers of fibrosis in dilated cardiomyopathy
Doctor P. Rubis (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Preservation of post-infarction cardiac structure and function with formyl peptide receptor agonist treatment
Doctor R. Garcia (Princeton, US)
Abstract Slides Video
Presentation thumbnail
Cardiac-specific deletion of Nrf2 drives adverse cardiac remodelling and progression to congestive cardiac failure during chronic pressure overload stress
Doctor A. Nabeebaccus (London, GB)
Abstract

Access the full session

Session thumbnail
Basic Science

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources